My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 170

    1.

    Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.

    Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M.

    Diabetes. 2002 Jun;51(6):1745-53.PMID: 12031961 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4.

    Varela-Calvino R, Sgarbi G, Arif S, Peakman M.

    Virology. 2000 Aug 15;274(1):56-64.PMID: 10936088 [PubMed - indexed for MEDLINE]Related articles

    3.

    T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity.

    Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M.

    J Immunol. 2001 Sep 15;167(6):3513-20.PMID: 11544345 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    T-cell responses to enterovirus antigens in children with type 1 diabetes.

    Juhela S, Hyöty H, Roivainen M, Härkönen T, Putto-Laurila A, Simell O, Ilonen J.

    Diabetes. 2000 Aug;49(8):1308-13.PMID: 10923630 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Induction of interferon-gamma and IL-4 production by mitogen and specific antigens in peripheral blood lymphocytes of Type 1 diabetes patients.

    Halminen M, Juhela S, Vaarala O, Simell O, Ilonen J.

    Autoimmunity. 2001;34(1):1-8.PMID: 11681488 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus.

    Klemetti P, Hyöty H, Roivainen M, Ilonen J, Savola K, Knip M, Akerblom HK, Vaarala O.

    J Clin Virol. 1999 Oct;14(2):95-105.PMID: 10588452 [PubMed - indexed for MEDLINE]Related articles

    7.

    Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.

    Varela-Calvino R, Skowera A, Arif S, Peakman M.

    J Virol. 2004 Dec;78(24):13399-408.PMID: 15564450 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects.

    Bruserud O, Jervell J, Thorsby E.

    Diabetologia. 1985 Jul;28(7):420-6.PMID: 2995183 [PubMed - indexed for MEDLINE]Related articles

    9.

    Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes.

    Skarsvik S, Puranen J, Honkanen J, Roivainen M, Ilonen J, Holmberg H, Ludvigsson J, Vaarala O.

    Diabetes. 2006 Apr;55(4):996-1003.PMID: 16567521 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.

    Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O'Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA.

    J Virol. 2005 Jan;79(2):1045-52.PMID: 15613333 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes.

    Hober D, Chehadeh W, Weill J, Hober C, Vantyghem MC, Gronnier P, Wattré P.

    J Gen Virol. 2002 Sep;83(Pt 9):2169-76.PMID: 12185270 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes.

    Marttila J, Hyöty H, Näntö-Salonen K, Simell O, Ilonen J.

    Virology. 2004 Feb 5;319(1):27-35.PMID: 14967485 [PubMed - indexed for MEDLINE]Related articles

    13.

    Using IFN-gamma as a biomarker for detecting exposure to viral pathogens.

    Li L, Dufour AP.

    Curr Microbiol. 2008 Jan;56(1):84-8. Epub 2007 Oct 10.PMID: 17926092 [PubMed - indexed for MEDLINE]Related articles

    14.

    T cell responses to type 1 diabetes related peptides sharing homologous regions.

    Sarugeri E, Dozio N, Meschi F, Pastore MR, Bonifacio E.

    J Mol Med. 2001 May;79(4):213-20.PMID: 11409713 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes.

    Mäkelä M, Oling V, Marttila J, Waris M, Knip M, Simell O, Ilonen J.

    Clin Exp Immunol. 2006 Aug;145(2):261-70.PMID: 16879245 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes.

    Monetini L, Barone F, Stefanini L, Petrone A, Walk T, Jung G, Thorpe R, Pozzilli P, Cavallo MG.

    J Endocrinol. 2003 Jan;176(1):143-50.PMID: 12525258 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes.

    Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW.

    Diabetes. 2009 Aug;58(8):1789-96. Epub 2009 Apr 28.PMID: 19401421 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.

    Chehadeh W, Lobert PE, Sauter P, Goffard A, Lucas B, Weill J, Vantyghem MC, Alm G, Pigny P, Hober D.

    J Virol. 2005 Nov;79(22):13882-91.PMID: 16254324 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patients.

    Sollid L, Bruserud O, Gaudernack G, Thorsby E.

    Scand J Immunol. 1986 Apr;23(4):461-7.PMID: 3010443 [PubMed - indexed for MEDLINE]Related articles

    20.

    In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients.

    Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, De Robertis O, Lattanzi V, Giorgino R.

    Diabetes Res Clin Pract. 1993 Aug-Sep;21(2-3):87-93.PMID: 8269823 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity